DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Dexamethasone (Dexamethasone) - Febrile Neutropenia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Febrile Neutropenia (105)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Dexamethasone where reactions include febrile neutropenia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 105   Next >>

Possible Dexamethasone side effects in 59 year old female

Reported by a physician from Japan on 2012-08-18

Patient: 59 year old female

Reactions: Febrile Neutropenia

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Breast Cancer

Dexamethasone
    Dosage: 8 mg

Dexamethasone
    Dosage: 8 mg
    Administration route: Oral
    Indication: Supportive Care

Docetaxel
    Indication: Breast Cancer



Possible Dexamethasone side effects in 36 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-17

Patient: 36 year old female

Reactions: Febrile Neutropenia

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Breast Cancer

Dexamethasone
    Dosage: 8 mg

Dexamethasone
    Dosage: 8 mg
    Administration route: Oral
    Indication: Supportive Care

Docetaxel
    Indication: Breast Cancer



Possible Dexamethasone side effects in male

Reported by a physician from United States on 2012-08-07

Patient: male

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dasatinib
    Dosage: one day
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-04-26

Dexamethasone

Doxorubicin Hydrochloride

Methotrexate
    Start date: 2012-05-11

Vincristine
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-03

Other drugs received by patient: Ondansetron; Glutamic Acid; Lorazepam; Morphine Sulfate; Bactrim



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-06

Patient:

Reactions: Anaphylactic Reaction, Pyrexia, Headache, Hyperhidrosis, Oedema Peripheral, Cough, Muscle Spasms, Diverticular Perforation, Back Pain, Pneumonia, Anaemia, Insomnia, Neutropenia, Stridor, Chills, Constipation, Hypokalaemia, Disease Progression, Fatigue, Dizziness, Thrombocytopenia, Enteritis, Dyspnoea, Nausea, Lymphopenia, Atrial Fibrillation, Febrile Neutropenia, Rash, Lung Disorder, Diarrhoea, Arthralgia, Sepsis, Bradycardia, Asthenia

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 milligram
    Administration route: Oral
    Indication: Multiple Myeloma

Elotuzumab
    Dosage: 5, 10 and 20 mg/kg
    Indication: Multiple Myeloma

Elotuzumab
    Dosage: 5, 10 and 20 mg/kg

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma



Possible Dexamethasone side effects in female

Reported by a physician from Belgium on 2012-08-03

Patient: female, weighing 62.0 kg (136.4 pounds)

Reactions: Anaemia, Febrile Neutropenia, Pyrexia, Lung Squamous Cell Carcinoma Stage Unspecified, Thrombocytopenia, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Administration route: Oral
    Start date: 2011-06-24
    End date: 2011-07-20

Dexamethasone
    Start date: 2012-07-04

Dexamethasone
    Administration route: Oral
    Start date: 2012-04-26

Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Start date: 2012-05-31

Dexamethasone
    Start date: 2012-07-02

Dexamethasone
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-01-05

Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    End date: 2012-06-27

Dexamethasone
    Start date: 2012-07-03

Revlimid
    Administration route: Oral
    Start date: 2011-02-03
    End date: 2011-04-20

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2012-04-26

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2011-06-24
    End date: 2011-12-28

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2012-05-30
    End date: 2012-06-27

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Start date: 2012-02-02

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2012-05-31

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-01-05

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2011-04-28
    End date: 2011-06-16

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2012-01-05
    End date: 2012-01-25

Other drugs received by patient: Aspirin; Cranberry Extract; RED Blood Cells; Paracodeine; Omeprazole; Pantoprazole; Flexium; Meropenem; Symbicort; Flexium; Cetavlex; Polyethylene Glycol; Sodium Chloride; Duovent; Aspirin; Bisoprolol Fumarate; R Calm Creme; RED Blood Cells; Platelets; Platelets; Whole Blood; Paracodeine



Possible Dexamethasone side effects in

Reported by a physician from United States on 2012-08-02

Patient:

Reactions: Electrocardiogram QT Prolonged, Hypokalaemia, Hypocalcaemia, Thrombocytopenia, Lethargy, Pneumonia, Nausea, Hyperglycaemia, Atrial Fibrillation, Febrile Neutropenia, Arthralgia, Diarrhoea, Dehydration, Neutropenia, Asthenia, Leukopenia

Drug(s) suspected as cause:
Dexamethasone
    Indication: Multiple Myeloma

Lenalidomide
    Dosage: 5 or 10mg (daily,days 1-21 of ea cycle)
    Administration route: Oral
    Indication: Multiple Myeloma

Treanda
    Dosage: 75 or 100mg/m2 (day 1 and 2 of ea cycle)
    Indication: Multiple Myeloma

Other drugs received by patient: Gastroprotectant; Acetylsalicylic Acid SRT



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-31

Patient:

Reactions: Mantle Cell Lymphoma Refractory, Skin Toxicity, Neurotoxicity, Neuropathy Peripheral, Hepatotoxicity, Cardiotoxicity, Thrombocytopenia, Renal Disorder, Drug Effect Decreased, Gastrointestinal Toxicity, Anaemia, Febrile Neutropenia, Toxicity To Various Agents, Mantle Cell Lymphoma, Lung Disorder, Neutropenia, Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Chlorambucil
    Dosage: from day 20 to 29.
    Indication: Mantle Cell Lymphoma

Dexamethasone
    Dosage: day 1 to 4
    Indication: Mantle Cell Lymphoma

Doxorubicin Hydrochloride
    Dosage: as a continuous infusion from day 1 to 4

Doxorubicin Hydrochloride
    Dosage: as a continuous infusion from day 1 to 4
    Indication: Mantle Cell Lymphoma

Rituximab
    Dosage: on day 1 (and day 8 of cycle 1)
    Indication: Mantle Cell Lymphoma

Velcade
    Dosage: on days 1, 4, 8 and 11
    Indication: Mantle Cell Lymphoma



Possible Dexamethasone side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30

Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)

Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Acute Myocardial Infarction, Clostridial Infection, Immunosuppression, Renal Failure Acute, Cardiac Failure Congestive, Pneumonia, Dyspnoea, Malnutrition, Febrile Neutropenia, Encephalopathy, Atrial Fibrillation, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-18
    End date: 2011-06-02

Dexamethasone
    End date: 2012-04-10

Prednisone
    Indication: Multiple Myeloma

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-20
    End date: 2011-06-09

Revlimid
    Administration route: Oral
    End date: 2012-05-01

Velcade
    Dosage: .2714 milligram
    Indication: Multiple Myeloma
    Start date: 2010-12-12
    End date: 2011-06-02

Velcade
    End date: 2012-04-10

Other drugs received by patient: Lotrel; Pravastatin; Vitamin D; Coreg; Doxepin; Tricore; Betaseron; Acyclovir; Allopurinol; Aspirin; Heocyte; Metformin Hydrochloride; Warfarin Sodium; Doxil



Possible Dexamethasone side effects in male

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-07-30

Patient: male

Reactions: Staphylococcal Infection, Atrial Flutter, Febrile Neutropenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Bortezomib
    Indication: Multiple Myeloma

Dexamethasone
    Administration route: Oral
    Indication: Multiple Myeloma

Romidepsin
    Indication: Multiple Myeloma

Other drugs received by patient: Bisphosphonates; Sulfamethoxazole and Trimethoprim; Valaciclovir



Possible Dexamethasone side effects in female

Reported by a physician from Belgium on 2012-07-30

Patient: female, weighing 62.6 kg (137.7 pounds)

Reactions: Anaemia, Febrile Neutropenia, Platelet Count Decreased, Pyrexia, Lung Squamous Cell Carcinoma Stage Unspecified

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Start date: 2012-07-02

Dexamethasone
    Start date: 2012-07-03

Dexamethasone
    Administration route: Oral
    Start date: 2011-06-24
    End date: 2011-07-20

Dexamethasone
    Administration route: Oral
    Start date: 2012-04-26

Dexamethasone
    Start date: 2012-07-04

Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Start date: 2012-05-31

Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    End date: 2012-06-27

Dexamethasone
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-01-05

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2011-04-28
    End date: 2011-06-16

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2012-01-05
    End date: 2012-01-25

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Start date: 2012-02-02

Revlimid
    Administration route: Oral
    Start date: 2011-02-03
    End date: 2011-04-20

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2011-06-24
    End date: 2011-12-28

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2012-04-26

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2012-05-31

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2012-05-30
    End date: 2012-06-27

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-01-05

Other drugs received by patient: R Calm Creme; RED Blood Cells; Cetavlex; Flexium; Platelets; Polyethylene Glycol; Aspirin; Meropenem; Bisoprolol Fumarate; Flexium; Sodium Chloride; Symbicort; Cranberry Extract; Pantoprazole



Possible Dexamethasone side effects in

Reported by a physician from Israel on 2012-07-28

Patient:

Reactions: Febrile Neutropenia, Hyponatraemia, Pyrexia, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded Aprepitant
    Administration route: Oral
    Start date: 2012-06-18
    End date: 2012-06-18

Blinded Aprepitant
    Administration route: Oral
    Start date: 2012-06-19
    End date: 2012-06-20

Blinded Aprepitant
    Administration route: Oral
    Start date: 2012-06-18
    End date: 2012-06-18

Blinded Aprepitant
    Administration route: Oral
    Start date: 2012-06-19
    End date: 2012-06-20

Blinded Ondansetron HCL
    Administration route: Oral
    Start date: 2012-06-18
    End date: 2012-06-18

Blinded Ondansetron HCL
    Administration route: Oral
    Start date: 2012-06-19
    End date: 2012-06-20

Blinded Post Trial Therapy
    Administration route: Oral
    Start date: 2012-06-18
    End date: 2012-06-18

Blinded Post Trial Therapy
    Administration route: Oral
    Start date: 2012-06-19
    End date: 2012-06-20

Blinded PRE Trial Therapy
    Administration route: Oral
    Start date: 2012-06-19
    End date: 2012-06-20

Blinded PRE Trial Therapy
    Administration route: Oral
    Start date: 2012-06-18
    End date: 2012-06-18

Cisplatin
    Dosage: 46.2 mg/kg, qd
    Indication: Chemotherapy
    Start date: 2012-06-18
    End date: 2012-06-18

Cytoxan
    Dosage: 172 mg, qd
    Indication: Chemotherapy
    Start date: 2012-06-19
    End date: 2012-06-20

Dexamethasone
    Administration route: Oral
    Start date: 2012-06-19
    End date: 2012-06-20

Dexamethasone
    Administration route: Oral
    Start date: 2012-06-18
    End date: 2012-06-18

Etoposide
    Dosage: 33 mg, qd
    Indication: Chemotherapy
    Start date: 2012-06-18
    End date: 2012-06-20

Ondansetron
    Administration route: Oral
    Indication: Prophylaxis of Nausea and Vomiting
    Start date: 2012-06-18
    End date: 2012-06-22

Placebo
    Administration route: Oral
    Start date: 2012-06-18
    End date: 2012-06-18

Placebo
    Administration route: Oral
    Start date: 2012-06-19
    End date: 2012-06-20

Vincristine Sulfate
    Dosage: 0.6 mg, qd
    Start date: 2012-06-24
    End date: 2012-06-24

Vincristine Sulfate
    Dosage: 0.66 mg, qd
    Start date: 2012-07-01
    End date: 2012-07-01

Vincristine Sulfate
    Dosage: 0.66 mg, qd
    Indication: Chemotherapy
    Start date: 2012-06-18
    End date: 2012-06-18

Other drugs received by patient: Dexacort (Dexamethasone Sodium Phosphate); Mesna; Resprim; Diamox



Possible Dexamethasone side effects in female

Reported by a physician from Sweden on 2012-07-26

Patient: female, weighing 68.5 kg (150.7 pounds)

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: 100mgm2 every 3 weeks
    Indication: Diffuse Large B-Cell Lymphoma Recurrent
    Start date: 2011-05-19

Cytarabine
    Dosage: 4gm2 every 3 weeks
    Indication: Diffuse Large B-Cell Lymphoma Recurrent
    Start date: 2011-05-20

Dexamethasone
    Dosage: 40mg every 3 weeks
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma Recurrent
    Start date: 2011-05-19

Ofatumumab
    Dosage: 1000mg cyclic
    Indication: Diffuse Large B-Cell Lymphoma Recurrent
    Start date: 2011-05-19



Possible Dexamethasone side effects in 1 year old male

Reported by a physician from United States on 2012-07-25

Patient: 1 year old male

Reactions: Adenovirus Infection, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Start date: 2011-05-27

Lestaurtinib
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-05-27

Mercaptopurine
    Start date: 2011-05-27

Methotrexate
    Start date: 2011-05-27

Vincristine
    Start date: 2011-05-27



Possible Dexamethasone side effects in male

Reported by a individual with unspecified qualification from United States on 2012-07-23

Patient: male, weighing 54.0 kg (118.8 pounds)

Reactions: White Blood Cell Count Decreased, Pneumonia, Chills, Anaemia, Febrile Neutropenia, Pyrexia, Oropharyngeal Pain, Fatigue, Respiratory Failure, Tachypnoea, Cough, Oxygen Saturation Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 135 mg

Mercaptopurine
    Dosage: 8000 mg

Methotrexate
    Dosage: 270 mg



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-23

Patient:

Reactions: Electrocardiogram QT Prolonged, Hypokalaemia, Hypocalcaemia, Thrombocytopenia, Lethargy, Pneumonia, Nausea, Hyperglycaemia, Febrile Neutropenia, Atrial Fibrillation, Arthralgia, Diarrhoea, Dehydration, Neutropenia, Asthenia, Leukopenia

Drug(s) suspected as cause:
Bendamustine Hydrochloride
    Dosage: 75 or 100mg/m2
    Indication: Multiple Myeloma

Dexamethasone
    Indication: Multiple Myeloma

Revlimid
    Dosage: 5 or 10mg
    Administration route: Oral
    Indication: Multiple Myeloma

Other drugs received by patient: Gastroprotectant; Aspirin



Possible Dexamethasone side effects in 42 year old female

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-07-20

Patient: 42 year old female

Reactions: Transient Psychosis, Febrile Neutropenia, Hallucination, Suicidal Ideation

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: on d1; part of act protocol; for 4 cycles
    Indication: Breast Cancer

Dexamethasone
    Dosage: 12mg
    Indication: Premedication

Dithiaden
    Dosage: 2mg
    Indication: Premedication

Docetaxel
    Dosage: for 4 cycles
    Indication: Breast Cancer

Doxorubicin HCL
    Dosage: on d1; part of act protocol; for 4 cycles
    Indication: Breast Cancer

Ondansetron
    Dosage: 8mg
    Indication: Antiemetic Supportive Care

Paclitaxel
    Dosage: over 1h on d1; part of act protocol; scheduled for 12w
    Indication: Breast Cancer

Ranitidine
    Dosage: 150mg
    Indication: Premedication



Possible Dexamethasone side effects in 42 year old female

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-07-20

Patient: 42 year old female

Reactions: Transient Psychosis, Febrile Neutropenia, Hallucination, Suicidal Ideation

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: on d1; part of act protocol; for 4 cycles
    Indication: Breast Cancer

Dexamethasone
    Dosage: 12mg
    Indication: Premedication

Dithiaden
    Dosage: 2mg
    Indication: Premedication

Docetaxel
    Dosage: for 4 cycles
    Indication: Breast Cancer

Doxorubicin HCL
    Dosage: on d1; part of act protocol; for 4 cycles
    Indication: Breast Cancer

Ondansetron
    Dosage: 8mg
    Indication: Antiemetic Supportive Care

Paclitaxel
    Dosage: over 1h on d1; part of act protocol; scheduled for 12w
    Indication: Breast Cancer

Ranitidine
    Dosage: 150mg
    Indication: Premedication



Possible Dexamethasone side effects in 42 year old female

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-07-20

Patient: 42 year old female

Reactions: Transient Psychosis, Febrile Neutropenia, Hallucination, Suicidal Ideation

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: on d1; part of act protocol; for 4 cycles
    Indication: Breast Cancer

Dexamethasone
    Dosage: 12mg
    Indication: Premedication

Dithiaden
    Dosage: 2mg
    Indication: Premedication

Docetaxel
    Dosage: for 4 cycles
    Indication: Breast Cancer

Doxorubicin HCL
    Dosage: on d1; part of act protocol; for 4 cycles
    Indication: Breast Cancer

Ondansetron
    Dosage: 8mg
    Indication: Antiemetic Supportive Care

Paclitaxel
    Dosage: over 1h on d1; part of act protocol; scheduled for 12w
    Indication: Breast Cancer

Ranitidine
    Dosage: 150mg
    Indication: Premedication



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-19

Patient:

Reactions: Mantle Cell Lymphoma Refractory, Skin Toxicity, Neurotoxicity, Neuropathy Peripheral, Hepatotoxicity, Cardiotoxicity, Thrombocytopenia, Drug Effect Decreased, Renal Disorder, Gastrointestinal Toxicity, Anaemia, Febrile Neutropenia, Toxicity To Various Agents, Mantle Cell Lymphoma, Lung Disorder, Neutropenia, Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Chlorambucil
    Dosage: from day 20 to 29.
    Indication: Mantle Cell Lymphoma

Dexamethasone
    Dosage: day 1 to 4
    Indication: Mantle Cell Lymphoma

Doxorubicin HCL
    Dosage: as a continuous infusion from day 1 to 4
    Indication: Mantle Cell Lymphoma

Rituximab
    Dosage: on day 1 (and day 8 of cycle 1)
    Indication: Mantle Cell Lymphoma

Velcade
    Dosage: on days 1, 4, 8 and 11
    Indication: Mantle Cell Lymphoma



Possible Dexamethasone side effects in 42 year old female

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-07-19

Patient: 42 year old female

Reactions: Febrile Neutropenia, Suicidal Ideation, Dysphemia, Anxiety, Hallucinations, Mixed, Transient Psychosis, Disturbance in Attention, Somatoform Disorder, Hallucination

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bisulepin
    Dosage: 2 mg
    Indication: Premedication

Dexamethasone
    Dosage: 12 mg
    Indication: Premedication

Ondansetron
    Dosage: 8 mg
    Indication: Premedication

Paclitaxel
    Dosage: 80 mg/m2, per week
    Indication: Breast Cancer

Ranitidine
    Dosage: 150 mg
    Indication: Premedication

Other drugs received by patient: Cyclophosphamide; Doxorubicin HCL



Possible Dexamethasone side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18

Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)

Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Death, Acute Myocardial Infarction, Clostridial Infection, Cardiac Failure Congestive, Immunosuppression, Renal Failure Acute, Pneumonia, Dyspnoea, Malnutrition, Atrial Fibrillation, Febrile Neutropenia, Encephalopathy, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-18
    End date: 2011-06-02

Dexamethasone
    End date: 2012-04-10

Prednisone
    Indication: Multiple Myeloma

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-20
    End date: 2011-06-09

Revlimid
    Administration route: Oral
    End date: 2012-05-01

Velcade
    End date: 2012-04-10

Velcade
    Dosage: .2714 milligram
    Indication: Multiple Myeloma
    Start date: 2010-12-12
    End date: 2011-06-02

Other drugs received by patient: Doxil; Coreg; Pravastatin; Heocyte; Betaseron; Lotrel; Aspirin; Vitamin D; Warfarin Sodium; Allopurinol; Doxepin; Acyclovir; Metformin Hydrochloride; Tricore



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18

Patient:

Reactions: Pneumonia, Nausea, Lymphopenia, Hyperglycaemia, Anaemia, Febrile Neutropenia, Constipation, Renal Failure, Neuropathy Peripheral, Fatigue, Diarrhoea, Embolism, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 500 milligram/sq. meter
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: 40 milligram
    Indication: Multiple Myeloma

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma

Revlimid
    Dosage: 15 milligram
    Administration route: Oral

Velcade
    Dosage: 1.3 milligram/sq. meter
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 milligram/sq. meter



Possible Dexamethasone side effects in

Reported by a physician from Israel on 2012-07-17

Patient:

Reactions: Febrile Neutropenia, Hyponatraemia, Pyrexia, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded Aprepitant
    Administration route: Oral
    Start date: 2012-06-19
    End date: 2012-06-20

Blinded Aprepitant
    Administration route: Oral
    Start date: 2012-06-19
    End date: 2012-06-20

Blinded Aprepitant
    Administration route: Oral
    Start date: 2012-06-18
    End date: 2012-06-18

Blinded Aprepitant
    Administration route: Oral
    Start date: 2012-06-18
    End date: 2012-06-18

Blinded Ondansetron HCL
    Administration route: Oral
    Start date: 2012-06-19
    End date: 2012-06-20

Blinded Ondansetron HCL
    Administration route: Oral
    Start date: 2012-06-18
    End date: 2012-06-18

Blinded Post Trial Therapy
    Administration route: Oral
    Start date: 2012-06-18
    End date: 2012-06-18

Blinded Post Trial Therapy
    Administration route: Oral
    Start date: 2012-06-19
    End date: 2012-06-20

Blinded PRE Trial Therapy
    Administration route: Oral
    Start date: 2012-06-18
    End date: 2012-06-18

Blinded PRE Trial Therapy
    Administration route: Oral
    Start date: 2012-06-19
    End date: 2012-06-20

Cisplatin
    Dosage: 46.2 mg/kg, qd
    Indication: Chemotherapy
    Start date: 2012-06-18
    End date: 2012-06-18

Cytoxan
    Dosage: 172 mg, qd
    Indication: Chemotherapy
    Start date: 2012-06-19
    End date: 2012-06-20

Dexamethasone
    Administration route: Oral
    Start date: 2012-06-19
    End date: 2012-06-20

Dexamethasone
    Administration route: Oral
    Start date: 2012-06-18
    End date: 2012-06-18

Etoposide
    Dosage: 33 mg, qd
    Indication: Chemotherapy
    Start date: 2012-06-18
    End date: 2012-06-20

Ondansetron
    Administration route: Oral
    Indication: Prophylaxis of Nausea and Vomiting
    Start date: 2012-06-18
    End date: 2012-06-22

Placebo
    Administration route: Oral
    Start date: 2012-06-19
    End date: 2012-06-20

Placebo
    Administration route: Oral
    Start date: 2012-06-18
    End date: 2012-06-18

Vincristine Sulfate
    Dosage: 0.66 mg, qd
    Indication: Chemotherapy
    Start date: 2012-06-18
    End date: 2012-06-18

Vincristine Sulfate
    Dosage: 0.6 mg, qd
    Start date: 2012-06-24
    End date: 2012-06-24

Vincristine Sulfate
    Dosage: 0.66 mg, qd
    Start date: 2012-07-01
    End date: 2012-07-01

Other drugs received by patient: Dexacort (Dexamethasone Sodium Phosphate); Resprim; Diamox; Mesna



Possible Dexamethasone side effects in 61 year old female

Reported by a physician from United States on 2012-07-13

Patient: 61 year old female, weighing 62.1 kg (136.7 pounds)

Reactions: Chills, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 20mg, day of+aft velcade
    Indication: Multiple Myeloma
    Start date: 2012-07-02
    End date: 2012-07-10

Velcade
    Dosage: 1.3mg, d 1,4,8,11
    Indication: Multiple Myeloma
    Start date: 2012-07-02
    End date: 2012-07-09

Other drugs received by patient: Acyclovir; Lovenox; Prilosec; Compazine; Oxycodone HCL; Ativan; Ondansetron Hydrochloride



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-13

Patient:

Reactions: Bacteraemia, Febrile Neutropenia, Haematotoxicity

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive

Cytarabine
    Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive

Dexamethasone
    Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive

Doxorubicin Hydrochloride
    Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive

Mabthera
    Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive

Methotrexate
    Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive

Vincristine
    Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive



Possible Dexamethasone side effects in

Reported by a individual with unspecified qualification from Croatia (Local Name: Hrvatska) on 2012-07-13

Patient:

Reactions: Mucosal Inflammation, Multi-Organ Failure, Tumour Lysis Syndrome, Febrile Neutropenia, Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Burkitt's Lymphoma

Cytarabine
    Indication: Burkitt's Lymphoma

Dexamethasone
    Indication: Burkitt's Lymphoma

Doxorubicin Hydrochloride
    Indication: Burkitt's Lymphoma

Etoposide
    Indication: Burkitt's Lymphoma

Ifosfamide
    Indication: Burkitt's Lymphoma

Mabthera
    Indication: Burkitt's Lymphoma

Methotrexate
    Indication: Burkitt's Lymphoma

Methylprednisolone
    Indication: Prophylaxis

Prednisone
    Indication: Burkitt's Lymphoma

Vincristine
    Indication: Burkitt's Lymphoma



Possible Dexamethasone side effects in female

Reported by a individual with unspecified qualification from Netherlands on 2012-07-13

Patient: female, weighing 54.0 kg (118.8 pounds)

Reactions: Febrile Neutropenia, Pyrexia, Convulsion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: last dose prior to sae 05/jun/2012
    Start date: 2012-06-05

Cisplatin
    Dosage: last dose prior to sae 05/may/2012
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-04

Cytarabine
    Dosage: last dose prior to sae 06/jun/2012
    Start date: 2012-06-06

Cytarabine
    Dosage: last dose prior to sae 05/may/2012
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-05

Dexamethasone
    Dosage: last dose prior to sae 07/may/2012
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-04

Dexamethasone
    Dosage: last dose prior to sae 08/jun/2012
    Start date: 2012-06-05

Mabthera
    Dosage: last dose prior to sae 08/may/2012
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-08

Mabthera
    Dosage: last dose prior to sae 09/jun/2012
    Start date: 2012-06-09

Other drugs received by patient: Augmentin '125'; Ciprofloxacin HCL; Nexium; Fungizone; Keppra; Keppra; Valganciclovir; Allopurinol



Possible Dexamethasone side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-13

Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)

Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Death, Acute Myocardial Infarction, Clostridial Infection, Renal Failure Acute, Immunosuppression, Cardiac Failure Congestive, Pneumonia, Dyspnoea, Malnutrition, Febrile Neutropenia, Atrial Fibrillation, Encephalopathy, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-18
    End date: 2011-06-02

Dexamethasone
    End date: 2012-04-10

Prednisone
    Indication: Multiple Myeloma

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-20
    End date: 2011-06-09

Revlimid
    Administration route: Oral
    End date: 2012-05-01

Velcade
    End date: 2012-04-10

Velcade
    Dosage: .2714 milligram
    Indication: Multiple Myeloma
    Start date: 2010-12-12
    End date: 2011-06-02

Other drugs received by patient: Betaseron; Lotrel; Coreg; Doxepin; Vitamin D; Warfarin Sodium; Pravastatin; Doxil; Acyclovir; Allopurinol; Heocyte; Tricore; Aspirin; Metformin Hydrochloride



Possible Dexamethasone side effects in 46 year old male

Reported by a physician from United States on 2012-07-12

Patient: 46 year old male

Reactions: Febrile Neutropenia, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 446 mg, unk

Cyclophosphamide
    Dosage: 630 mg, q12h
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Dexamethasone
    Dosage: 40 mg, unk
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17

Doxorubicin HCL
    Dosage: 56.5 mg, unk
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Doxorubicin HCL
    Dosage: 37 mg, unk

Mesna
    Dosage: 1116 mg, unk
    Indication: non-Hodgkin's Lymphoma

Pegfilgrastim
    Dosage: 6 mg, unk
    Indication: non-Hodgkin's Lymphoma

Rituxan
    Dosage: 698 mg, unk
    Start date: 2012-05-02

Rituxan
    Dosage: 787.5 mg, unk
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17
    End date: 2012-02-22

Vincristine Sulfate
    Dosage: 2 mg, unk
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-17

Other drugs received by patient: MS Contin; Valtrex; Omeprazole; Ciprofloxacin; Morphine Sulfate; Enoxaparin / 01708202 /; Compazine; Fluconazole; Metoprolol Tartrate



Possible Dexamethasone side effects in 61 year old female

Reported by a physician from United States on 2012-07-11

Patient: 61 year old female, weighing 61.4 kg (135.1 pounds)

Reactions: Anaemia, Chills, Febrile Neutropenia, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: day of and after velcade
    Indication: Multiple Myeloma
    Start date: 2012-07-02
    End date: 2012-07-03

Revlimid
    Dosage: days 1-14
    Indication: Multiple Myeloma
    Start date: 2012-07-02
    End date: 2012-07-03

Velcade
    Dosage: days 1, 4, 8, 11
    Indication: Multiple Myeloma
    Start date: 2012-07-02
    End date: 2012-07-02

Other drugs received by patient: Prilosec; Lovenox; Acyclovir



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017